The pharmacological properties of cannabis
@inproceedings{Nahtigal2017ThePP, title={The pharmacological properties of cannabis}, author={Istok G. Nahtigal and Alexia Blake and Andrew Hand and Angelique Florentinus-Mefailoski and Haleh Hashemi and Jeremy Friedberg}, year={2017} }
The efforts to understand the nature of how the consumption of cannabis affects the human body are ongoing, complex, and multifaceted. Documentation on the use of cannabis dates back thousands of years; however, it is only now with the recent softening of legal restrictions that modern research approaches have been able to initiate an appropriate level of detailed investigations. For clinicians, researchers and policy makers, this chapter reviews the general structure of cannabinoids, the…
13 Citations
A Review of the Pharmacology and Anesthetic Implications of Cannabis.
- MedicineAANA journal
- 2020
The purpose of this article is to describe cannabis and its pharmacologic and physiologic effects and to review the anesthetic implications of its short-term and long-term use.
Challenges and Opportunities in Preclinical Research of Synthetic Cannabinoids for Pain Therapy
- BiologyMedicina
- 2020
Synthetic cannabinoids are one of the most promising classes of drugs in pain medicine, and preclinical research should focus on identifying new and improved alternatives for a better clinical and pre clinical outcome.
Cannabis and cannabinoids as an alternative remedy in metabolic syndrome
- Biology, MedicineBrazilian Journal of Pharmaceutical Sciences
- 2022
This review aims to determine under what conditions Cannabis might be useful in the treatment of MetS, and identifies pharmacological approaches that represent a source of new therapeutic agents for MetS.
Exogenous Cannabinoid Efficacy: Merely a Pharmacokinetic Interaction?
- Biology, ChemistryClinical Pharmacokinetics
- 2017
The key pharmacological knowledge required to guide further exploration of the toxicity and efficacy of different cannabinoids and their formulations in blinded placebo-controlled studies are covered.
Medical cannabis: What practitioners need to know.
- MedicineSouth African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
- 2020
Evidence supporting benefit from medical cannabis exists for two drug-resistant childhood forms of epilepsy, Dravet syndrome and Lennox-Gastaut syndrome, and low-level or no convincing evidence exists for the use of medical cannabis for chronic pain, sleep and weight disorders, and neuropsychiatric disorders.
Clinical Research Evidence Supporting Administration and Dosing Recommendations of Medicinal Cannabis as Analgesic in Cancer Patients
- Medicine, BiologyJournal of clinical medicine
- 2022
Clinical research supporting administration of medicinal cannabis in cancer patients for analgesic purposes is elucidated, and high-quality RCTs are scarce in this research field, and the limitations of the observational studies complicates interpretation of clinical outcomes.
Antimicrobial and Antiviral (SARS-CoV-2) Potential of Cannabinoids and Cannabis sativa: A Comprehensive Review
- BiologyMolecules
- 2021
This paper comprehensively reviews the antimicrobial and antiviral properties of C. sativa with the potential for new antibiotic drug and/or natural antimicrobial agents for industrial or agricultural use, and their therapeutic potential against the newly emerged coronavirus disease (COVID-19).
Exploring the Use of Medical Marijuana for Supportive Care of Oncology Patients
- MedicineJournal of the advanced practitioner in oncology
- 2021
A medical marijuana guideline committee was appointed to create guidelines for the nursing care of patients using medical marijuana, marijuana education in nursing programs, and guidelines for advanced practice registered nurses (APRNs) certifying a patient for the use of medical marijuana.
Future Aspects for Cannabinoids in Breast Cancer Therapy
- Biology, MedicineInternational journal of molecular sciences
- 2019
Cannabinoids are already administered to breast cancer patients at advanced stages of the disease, but they might also be effective at earlier stages to decelerate tumor progression.
Empirical Evaluation of Inflorescences’ Morphological Attributes for Yield Optimization of Medicinal Cannabis Cultivars
- MedicineFrontiers in Plant Science
- 2022
In recent decades with the reacknowledgment of the medicinal properties of Cannabis sativa L. (cannabis) plants, there is an increased demand for high performing cultivars that can deliver quality…
References
SHOWING 1-10 OF 70 REFERENCES
Chemistry, Metabolism, and Toxicology of Cannabis: Clinical Implications
- BiologyIranian journal of psychiatry
- 2012
An attempt has been made to summarize the properties of cannabis and its derivatives, and to discuss the implications of its use with emphasis on bioavailability, limit of detection, carry over period and passive inhalation, important factors for detection and diagnosis.
Chemical constituents of marijuana: the complex mixture of natural cannabinoids.
- BiologyLife sciences
- 2005
Human Cannabinoid Pharmacokinetics
- Biology, ChemistryChemistry & biodiversity
- 2007
The cardiovascular and subjective effects of cannabis are blocked by rimonabant, the first CB-1 cannabinoid-receptor antagonist, documenting thatCB-1 receptors mediate these effects of smoked cannabis in humans.
Cannabidiol: An Overview of Some Pharmacological Aspects
- MedicineJournal of clinical pharmacology
- 2002
The authors present a review on the chemistry of CBD and discuss the anticonvulsive, antianxiety, antipsychotic, antinausea, and antirheumatoid arthritic properties of CBD.
Chemistry and Analysis of Phytocannabinoids and Other Cannabis Constituents
- Chemistry
- 2007
The Cannabis plant and its products consist of an enormous variety of chemicals. Some of the 483 compounds identified are unique to Cannabis, for example, the more than 60 cannabinoids, whereas the…
Neural correlates of interactions between cannabidiol and Δ9‐tetrahydrocannabinol in mice: implications for medical cannabis
- BiologyBritish journal of pharmacology
- 2016
The aim of this study was to investigate whether CBD modulated the functional effects and c‐Fos expression induced by THC, using a 1:1 dose ratio that approximates therapeutic strains of cannabis and nabiximols.
Cannabis and Cannabis Extracts: Greater Than the Sum of Their Parts?
- Medicine
- 2001
Good evidence shows that secondary compounds in cannabis may enhance the beneficial effects of THC, and other cannabinoid and non-cannabinoid compounds in herbal cannabis or its extracts may reduce THC-induced anxiety, cholinergic deficits, and immunosuppression.
Cannabidiol in Humans—The Quest for Therapeutic Targets
- Psychology, MedicinePharmaceuticals
- 2012
Preliminary clinical trials suggest that high-dose oral CBD may exert a therapeutic effect for social anxiety disorder, insomnia and epilepsy, but also that it may cause mental sedation.
Overcoming the Bell-Shaped Dose-Response of Cannabidiol by Using Cannabis Extract Enriched in Cannabidiol
- Biology
- 2015
It is proposed that Cannabis clone 202 (Avidekel) extract is superior over CBD for the treatment of inflammatory conditions and reduced zymosan-induced paw swelling and pain in mice, and prevented TNFα production in vivo.
Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures — A short review
- Biology, MedicinePharmacology Biochemistry and Behavior
- 2008